MedTrace Logo

Elizabeth Registry for Low Grade Ovarian Cancer

NCT00345709 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2015-10-07

No results posted yet for this study

Summary

Long-Term Objectives:

* To establish an ongoing national research registry of epidemiologic, clinical and pathologic data on low grade and low malignant potential (LMP) ovarian cancer patients in UTMDACC's Department of Gynecologic Oncology for research purposes.
* To create a bank of low grade and LMP ovarian cancer tumor blocks for study of the molecular and histopathologic differences among low grade ovarian cancer, ovarian LMP tumors and high grade ovarian cancer.
* To specify the epidemiologic and clinical profile of low grade and LMP ovarian cancer patients.
* To identify potential precursors of low grade and LMP ovarian cancer.
* To assess treatment patterns to guide management of these diseases.
* To collect quality of life and health outcomes data on these patients.
* To achieve a fundamental understanding of low grade and LMP ovarian cancer that will inform prevention and screening efforts, motivate development of improved treatments and eventually result in a cure.

The short-term objectives are:

* To detail procedures for potential registrant identification and recruitment.
* To create a demographic and health history questionnaire for potential registrants.
* To begin aggregating low grade and low malignant potential ovarian tumor blocks.
* To specify a timeline for the development of all other aspects of the Registry.

Conditions

Interventions

BEHAVIORAL

Questionnaire

65 page questionnaire that contains questions about your ovarian cancer diagnosis, gynecologic history, family history, general medical history, and health risk factors.

Sponsors & Collaborators

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Diane C. Bodurka, MD · M.D. Anderson Cancer Center

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-09-30
Primary Completion
2014-10-31
Completion
2014-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00345709 on ClinicalTrials.gov